Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
UnitedHealth launches new Level2 digital health therapy » 13:11
07/13/20
07/13
13:11
07/13/20
13:11
UNH

UnitedHealth

$300.68 /

+9.375 (+3.22%)

UnitedHealth Group…

UnitedHealth Group earlier announced that it has launched an innovative new therapy that combines wearable technology and customized personal support to help improve the health of people living with type 2 diabetes. The company said the therapy - known as Level2 - helps eligible participants gain real-time insights about their condition and, for some, successfully reduce spikes in blood sugar levels or even achieve type 2 diabetes remission. "Level2 equips eligible participants with integrated tools that include a mobile continuous glucose monitor, activity tracker, app-based alerts and one-on-one clinical coaching to help encourage healthier lifestyle decisions, such as food choices, exercise and sleep patterns. In the future, UnitedHealth Group may offer the Level2 model to support people with other chronic conditions beyond type 2 diabetes."

ShowHide Related Items >><<
UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

07/07/20 Cantor Fitzgerald
UnitedHealth likely to reiterate 2020 outlook, says Cantor Fitzgerald
07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
07/01/20 SVB Leerink
UnitedHealth reinstated with an Outperform at SVB Leerink
06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

Thursday
Recommendations
Tandem, Medtronic deal meant to mitigate litigation risk, says Piper Sandler » 11:02
07/09/20
07/09
11:02
07/09/20
11:02
TNDM

TNDM

/

+

, MDT

Medtronic

$90.48 /

-1.16 (-1.27%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien says Tandem Diabetes' (TNDM) non-exclusive patent cross-license agreement with Medtronic (MDT) for certain technologies relating to diabetes is meant to mitigate any potential legal disagreements. The agreement has certain exclusions and includes a provision not to clone each other's products.

ShowHide Related Items >><<
TNDM TNDM
/

+

MDT Medtronic
$90.48 /

-1.16 (-1.27%)

TNDM TNDM
/

+

07/07/20 Cowen
Tandem Diabetes price target raised to $110 from $85 at Cowen
07/06/20
Fly Intel: Top five analyst upgrades
07/06/20 Citi
Tandem Diabetes upgraded to Buy from Neutral at Citi
07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
MDT Medtronic
$90.48 /

-1.16 (-1.27%)

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
TNDM TNDM
/

+

MDT Medtronic
$90.48 /

-1.16 (-1.27%)

MDT Medtronic
$90.48 /

-1.16 (-1.27%)

TNDM TNDM
/

+

MDT Medtronic
$90.48 /

-1.16 (-1.27%)

MDT Medtronic
$90.48 /

-1.16 (-1.27%)

Hot Stocks
Medtronic, Tandem enter non-exclusive patent cross-license agreement » 11:01
07/09/20
07/09
11:01
07/09/20
11:01
MDT

Medtronic

$90.40 /

-1.24 (-1.35%)

, TNDM

TNDM

/

+

Medtronic (MDT) and…

Medtronic (MDT) and Tandem Diabetes Care (TNDM) announced earlier that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes. "Cross-licensing each other's patent portfolios enables both companies to focus on helping people with diabetes through innovation of future products and services, while avoiding the distraction of potential legal disagreements," they said in a statement. The companies added, "With certain exclusions, this agreement applies to the companies' existing products, as well as new products for at least the next five years, and also includes a provision not to clone one another's products. No payments will be exchanged as part of this agreement and further terms were not disclosed."

ShowHide Related Items >><<
TNDM TNDM
/

+

MDT Medtronic
$90.40 /

-1.24 (-1.35%)

MDT Medtronic
$90.40 /

-1.24 (-1.35%)

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
TNDM TNDM
/

+

07/07/20 Cowen
Tandem Diabetes price target raised to $110 from $85 at Cowen
07/06/20
Fly Intel: Top five analyst upgrades
07/06/20 Citi
Tandem Diabetes upgraded to Buy from Neutral at Citi
07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
TNDM TNDM
/

+

MDT Medtronic
$90.40 /

-1.24 (-1.35%)

MDT Medtronic
$90.40 /

-1.24 (-1.35%)

TNDM TNDM
/

+

MDT Medtronic
$90.40 /

-1.24 (-1.35%)

MDT Medtronic
$90.40 /

-1.24 (-1.35%)

Wednesday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:18
07/08/20
07/08
16:18
07/08/20
16:18
LEVI

Levi Strauss

$12.68 /

-1.195 (-8.62%)

, FB

Facebook

$243.58 /

+2.51 (+1.04%)

, BIIB

Biogen

$280.15 /

+11.97 (+4.46%)

, ALL

Allstate

$88.20 /

-4.38 (-4.73%)

, NGHC

National General

$33.73 /

+13.29 (+65.02%)

, TWTR

Twitter

$35.39 /

+2.41 (+7.31%)

, MRNA

Moderna

$61.58 /

+0.5 (+0.82%)

, GM

General Motors

$24.93 /

-0.19 (-0.76%)

, FCAU

Fiat Chrysler

$9.99 /

-0.09 (-0.89%)

, XENT

Intersect ENT

$17.98 /

+4.07 (+29.26%)

, MDT

Medtronic

$91.64 /

-0.05 (-0.05%)

, NKLA

Nikola

$54.03 /

+13.78 (+34.24%)

, GILT

Gilat Satellite

$5.20 /

-0.905 (-14.82%)

, CMTL

Comtech

$15.87 /

+0.32 (+2.06%)

Stocks continue to rise…

Open Full Text

ShowHide Related Items >><<
XENT Intersect ENT
$17.98 /

+4.07 (+29.26%)

TWTR Twitter
$35.39 /

+2.41 (+7.31%)

NKLA Nikola
$54.03 /

+13.78 (+34.24%)

NGHC National General
$33.73 /

+13.29 (+65.02%)

MRNA Moderna
$61.58 /

+0.5 (+0.82%)

MDT Medtronic
$91.64 /

-0.05 (-0.05%)

LEVI Levi Strauss
$12.68 /

-1.195 (-8.62%)

GM General Motors
$24.93 /

-0.19 (-0.76%)

GILT Gilat Satellite
$5.20 /

-0.905 (-14.82%)

FCAU Fiat Chrysler
$9.99 /

-0.09 (-0.89%)

FB Facebook
$243.58 /

+2.51 (+1.04%)

CMTL Comtech
$15.87 /

+0.32 (+2.06%)

BIIB Biogen
$280.15 /

+11.97 (+4.46%)

ALL Allstate
$88.20 /

-4.38 (-4.73%)

LEVI Levi Strauss
$12.68 /

-1.195 (-8.62%)

06/16/20 Exane BNP Paribas
Levi Strauss initiated with an Outperform at Exane BNP Paribas
04/09/20 Guggenheim
Levi Strauss price target lowered to $16 from $26 at Guggenheim
04/08/20 Citi
Levi Strauss has ample liquidity and remains 'strong brand,' says Citi
03/18/20 BofA
Levi Strauss downgraded to Neutral with $15 price target at BofA
FB Facebook
$243.58 /

+2.51 (+1.04%)

07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
07/01/20 Monness Crespi
Facebook has opportunity to emerge from crisis stronger, says Monness Crespi
07/01/20 Goldman Sachs
Facebook checks show limited impact from ad boycott, says Goldman Sachs
BIIB Biogen
$280.15 /

+11.97 (+4.46%)

07/08/20 Credit Suisse
Biogen submits Aducanumab BLA, upside possible near-term, says Credit Suisse
07/08/20 Stifel
Biogen submission of Aducanumab BLA 'an incremental positive,' says Stifel
07/08/20 Goldman Sachs
Goldman says Biogen BLA submission for Alzheimer's drug an incremental positive
07/08/20 Jefferies
Biogen likely to get Priority Review for aducanumab, says Jefferies
ALL Allstate
$88.20 /

-4.38 (-4.73%)

07/09/20 B. Riley FBR
National General downgraded to Neutral from Buy at B. Riley FBR
07/09/20 Citi
Allstate acquisition of National an incremental positive, says Citi
07/09/20 JMP Securities
National General downgraded to Market Perform from Outperform at JMP Securities
07/08/20 William Blair
National General downgraded to Market Perform from Outperform at William Blair
NGHC National General
$33.73 /

+13.29 (+65.02%)

07/09/20 B. Riley FBR
National General downgraded to Neutral from Buy at B. Riley FBR
TWTR Twitter
$35.39 /

+2.41 (+7.31%)

07/09/20 Citi
Twitter shares overreacted to paid service potential, says Citi
07/08/20 Rosenblatt
Rosenblatt says 'highly unlikely' Twitter considering paid subscription tiers
06/30/20 Morgan Stanley
Morgan Stanley says buy Facebook amid boycott-driven weakness
06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
MRNA Moderna
$61.58 /

+0.5 (+0.82%)

07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
GM General Motors
$24.93 /

-0.19 (-0.76%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
FCAU Fiat Chrysler
$9.99 /

-0.09 (-0.89%)

06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/22/20 Redburn
Fiat Chrysler upgraded to Buy from Neutral at Redburn
XENT Intersect ENT
$17.98 /

+4.07 (+29.26%)

07/08/20 Oppenheimer
Takeout bid of $17 for Intersect ENT would be 'reasonable,' says Oppenheimer
06/23/20 Oppenheimer
Intersect ENT initiated with a Perform at Oppenheimer
06/09/20 SVB Leerink
Intersect ENT C-code issuance has 'mixed implications,' says SVB Leerink
06/09/20 Piper Sandler
Intersect ENT's C-Code approval adds access to 40M lives, says Piper Sandler
MDT Medtronic
$91.64 /

-0.05 (-0.05%)

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
NKLA Nikola
$54.03 /

+13.78 (+34.24%)

07/08/20
Fly Intel: Top five analyst upgrades
07/08/20 JPMorgan
JPMorgan upgrades Nikola to Overweight after 40% July selloff
07/08/20 JPMorgan
Nikola upgraded to Overweight from Neutral at JPMorgan
07/07/20 RBC Capital
Nikola initiated with a Sector Perform at RBC Capital
GILT Gilat Satellite
$5.20 /

-0.905 (-14.82%)

CMTL Comtech
$15.87 /

+0.32 (+2.06%)

06/04/20 Northland
Comtech price target lowered to $24 from $27 at Northland
03/31/20 Citi
Comtech price target lowered to $17 from $34 at Citi
XENT Intersect ENT
$17.98 /

+4.07 (+29.26%)

TWTR Twitter
$35.39 /

+2.41 (+7.31%)

NGHC National General
$33.73 /

+13.29 (+65.02%)

MRNA Moderna
$61.58 /

+0.5 (+0.82%)

MDT Medtronic
$91.64 /

-0.05 (-0.05%)

LEVI Levi Strauss
$12.68 /

-1.195 (-8.62%)

GM General Motors
$24.93 /

-0.19 (-0.76%)

GILT Gilat Satellite
$5.20 /

-0.905 (-14.82%)

FCAU Fiat Chrysler
$9.99 /

-0.09 (-0.89%)

FB Facebook
$243.58 /

+2.51 (+1.04%)

CMTL Comtech
$15.87 /

+0.32 (+2.06%)

BIIB Biogen
$280.15 /

+11.97 (+4.46%)

ALL Allstate
$88.20 /

-4.38 (-4.73%)

  • 19
    May
  • 12
    Feb
XENT Intersect ENT
$17.98 /

+4.07 (+29.26%)

TWTR Twitter
$35.39 /

+2.41 (+7.31%)

NKLA Nikola
$54.03 /

+13.78 (+34.24%)

MRNA Moderna
$61.58 /

+0.5 (+0.82%)

MDT Medtronic
$91.64 /

-0.05 (-0.05%)

LEVI Levi Strauss
$12.68 /

-1.195 (-8.62%)

GM General Motors
$24.93 /

-0.19 (-0.76%)

GILT Gilat Satellite
$5.20 /

-0.905 (-14.82%)

FB Facebook
$243.58 /

+2.51 (+1.04%)

BIIB Biogen
$280.15 /

+11.97 (+4.46%)

XENT Intersect ENT
$17.98 /

+4.07 (+29.26%)

TWTR Twitter
$35.39 /

+2.41 (+7.31%)

NKLA Nikola
$54.03 /

+13.78 (+34.24%)

MRNA Moderna
$61.58 /

+0.5 (+0.82%)

MDT Medtronic
$91.64 /

-0.05 (-0.05%)

LEVI Levi Strauss
$12.68 /

-1.195 (-8.62%)

GM General Motors
$24.93 /

-0.19 (-0.76%)

FCAU Fiat Chrysler
$9.99 /

-0.09 (-0.89%)

FB Facebook
$243.58 /

+2.51 (+1.04%)

CMTL Comtech
$15.87 /

+0.32 (+2.06%)

BIIB Biogen
$280.15 /

+11.97 (+4.46%)

ALL Allstate
$88.20 /

-4.38 (-4.73%)

TWTR Twitter
$35.39 /

+2.41 (+7.31%)

NKLA Nikola
$54.03 /

+13.78 (+34.24%)

MRNA Moderna
$61.58 /

+0.5 (+0.82%)

MDT Medtronic
$91.64 /

-0.05 (-0.05%)

LEVI Levi Strauss
$12.68 /

-1.195 (-8.62%)

GM General Motors
$24.93 /

-0.19 (-0.76%)

FCAU Fiat Chrysler
$9.99 /

-0.09 (-0.89%)

FB Facebook
$243.58 /

+2.51 (+1.04%)

BIIB Biogen
$280.15 /

+11.97 (+4.46%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:01
07/08/20
07/08
12:01
07/08/20
12:01
FB

Facebook

$238.53 /

-2.54 (-1.05%)

, BIIB

Biogen

$282.02 /

+13.84 (+5.16%)

, ALL

Allstate

$89.20 /

-3.38 (-3.65%)

, NGHC

National General

$33.60 /

+13.155 (+64.36%)

, XENT

Intersect ENT

$17.96 /

+4.05 (+29.12%)

, MDT

Medtronic

$90.66 /

-1.03 (-1.12%)

, NKLA

Nikola

$49.02 /

+8.77 (+21.79%)

, GILT

Gilat Satellite

$5.21 /

-0.895 (-14.66%)

, CMTL

Comtech

$15.69 /

+0.14 (+0.90%)

Stocks are marginally…

Open Full Text

ShowHide Related Items >><<
XENT Intersect ENT
$17.96 /

+4.05 (+29.12%)

NKLA Nikola
$49.02 /

+8.77 (+21.79%)

NGHC National General
$33.60 /

+13.155 (+64.36%)

MDT Medtronic
$90.66 /

-1.03 (-1.12%)

GILT Gilat Satellite
$5.21 /

-0.895 (-14.66%)

FB Facebook
$238.53 /

-2.54 (-1.05%)

CMTL Comtech
$15.69 /

+0.14 (+0.90%)

BIIB Biogen
$282.02 /

+13.84 (+5.16%)

ALL Allstate
$89.20 /

-3.38 (-3.65%)

FB Facebook
$238.53 /

-2.54 (-1.05%)

07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
07/01/20 Monness Crespi
Facebook has opportunity to emerge from crisis stronger, says Monness Crespi
07/01/20 Goldman Sachs
Facebook checks show limited impact from ad boycott, says Goldman Sachs
06/30/20 Morgan Stanley
Morgan Stanley says buy Facebook amid boycott-driven weakness
BIIB Biogen
$282.02 /

+13.84 (+5.16%)

07/08/20 Credit Suisse
Biogen submits Aducanumab BLA, upside possible near-term, says Credit Suisse
07/08/20 Stifel
Biogen submission of Aducanumab BLA 'an incremental positive,' says Stifel
07/08/20 Goldman Sachs
Goldman says Biogen BLA submission for Alzheimer's drug an incremental positive
07/08/20 Jefferies
Biogen likely to get Priority Review for aducanumab, says Jefferies
ALL Allstate
$89.20 /

-3.38 (-3.65%)

07/08/20 William Blair
National General downgraded to Market Perform from Outperform at William Blair
07/08/20 B. Riley FBR
National General price target raised to $34.50 from $28 at B. Riley FBR
06/25/20
Fly Intel: Top five analyst upgrades
06/25/20 Credit Suisse
Allstate upgraded to Neutral from Underperform at Credit Suisse
NGHC National General
$33.60 /

+13.155 (+64.36%)

04/08/20
Fly Intel: Top five analyst initiations
04/08/20 JPMorgan
National General initiated with a Neutral at JPMorgan
XENT Intersect ENT
$17.96 /

+4.05 (+29.12%)

06/23/20 Oppenheimer
Intersect ENT initiated with a Perform at Oppenheimer
06/09/20 SVB Leerink
Intersect ENT C-code issuance has 'mixed implications,' says SVB Leerink
06/09/20 Piper Sandler
Intersect ENT's C-Code approval adds access to 40M lives, says Piper Sandler
05/12/20 Canaccord
Intersect ENT downgraded to Hold from Buy at Canaccord
MDT Medtronic
$90.66 /

-1.03 (-1.12%)

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
NKLA Nikola
$49.02 /

+8.77 (+21.79%)

07/08/20
Fly Intel: Top five analyst upgrades
07/08/20 JPMorgan
JPMorgan upgrades Nikola to Overweight after 40% July selloff
07/08/20 JPMorgan
Nikola upgraded to Overweight from Neutral at JPMorgan
07/07/20 RBC Capital
Nikola initiated with a Sector Perform at RBC Capital
GILT Gilat Satellite
$5.21 /

-0.895 (-14.66%)

CMTL Comtech
$15.69 /

+0.14 (+0.90%)

06/04/20 Northland
Comtech price target lowered to $24 from $27 at Northland
03/31/20 Citi
Comtech price target lowered to $17 from $34 at Citi
XENT Intersect ENT
$17.96 /

+4.05 (+29.12%)

NGHC National General
$33.60 /

+13.155 (+64.36%)

MDT Medtronic
$90.66 /

-1.03 (-1.12%)

GILT Gilat Satellite
$5.21 /

-0.895 (-14.66%)

FB Facebook
$238.53 /

-2.54 (-1.05%)

CMTL Comtech
$15.69 /

+0.14 (+0.90%)

BIIB Biogen
$282.02 /

+13.84 (+5.16%)

ALL Allstate
$89.20 /

-3.38 (-3.65%)

XENT Intersect ENT
$17.96 /

+4.05 (+29.12%)

NKLA Nikola
$49.02 /

+8.77 (+21.79%)

MDT Medtronic
$90.66 /

-1.03 (-1.12%)

GILT Gilat Satellite
$5.21 /

-0.895 (-14.66%)

FB Facebook
$238.53 /

-2.54 (-1.05%)

BIIB Biogen
$282.02 /

+13.84 (+5.16%)

XENT Intersect ENT
$17.96 /

+4.05 (+29.12%)

NKLA Nikola
$49.02 /

+8.77 (+21.79%)

MDT Medtronic
$90.66 /

-1.03 (-1.12%)

FB Facebook
$238.53 /

-2.54 (-1.05%)

CMTL Comtech
$15.69 /

+0.14 (+0.90%)

BIIB Biogen
$282.02 /

+13.84 (+5.16%)

ALL Allstate
$89.20 /

-3.38 (-3.65%)

NKLA Nikola
$49.02 /

+8.77 (+21.79%)

MDT Medtronic
$90.66 /

-1.03 (-1.12%)

FB Facebook
$238.53 /

-2.54 (-1.05%)

BIIB Biogen
$282.02 /

+13.84 (+5.16%)

Over a week ago
Periodicals
Intersect ENT reviewing Medtronic takeover offer, Bloomberg says » 20:59
07/07/20
07/07
20:59
07/07/20
20:59
XENT

Intersect ENT

$13.91 /

-0.25 (-1.77%)

, MDT

Medtronic

$91.69 /

-1.51 (-1.62%)

Intersect's (XENT)…

Intersect's (XENT) board of directors is reviewing the offer made by Medtronic (MDT), Bloomberg's Nabila Ahmed and Ed Hammond report, citing people familiar with the matter. The report adds that the discussions are in the early stages and Medtronic's plans could still change. Reference Link

ShowHide Related Items >><<
XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

06/23/20 Oppenheimer
Intersect ENT initiated with a Perform at Oppenheimer
06/09/20 SVB Leerink
Intersect ENT C-code issuance has 'mixed implications,' says SVB Leerink
06/09/20 Piper Sandler
Intersect ENT's C-Code approval adds access to 40M lives, says Piper Sandler
05/12/20 Canaccord
Intersect ENT downgraded to Hold from Buy at Canaccord
MDT Medtronic
$91.69 /

-1.51 (-1.62%)

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

Periodicals
Medtronic makes bid to acquire Intersect ENT, Bloomberg says  19:24
07/07/20
07/07
19:24
07/07/20
19:24
XENT

Intersect ENT

$13.91 /

-0.25 (-1.77%)

, MDT

Medtronic

$91.69 /

-1.51 (-1.62%)

 
ShowHide Related Items >><<
XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

06/23/20 Oppenheimer
Intersect ENT initiated with a Perform at Oppenheimer
06/09/20 SVB Leerink
Intersect ENT C-code issuance has 'mixed implications,' says SVB Leerink
06/09/20 Piper Sandler
Intersect ENT's C-Code approval adds access to 40M lives, says Piper Sandler
05/12/20 Canaccord
Intersect ENT downgraded to Hold from Buy at Canaccord
MDT Medtronic
$91.69 /

-1.51 (-1.62%)

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

XENT Intersect ENT
$13.91 /

-0.25 (-1.77%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

MDT Medtronic
$91.69 /

-1.51 (-1.62%)

Recommendations
Tandem Diabetes price target raised to $110 from $85 at Cowen » 09:20
07/07/20
07/07
09:20
07/07/20
09:20
TNDM

TNDM

/

+

Cowen analyst Ryan…

Cowen analyst Ryan Blicker raised the firm's price target on Tandem Diabetes to $110 from $85 and keeps an Outperform rating on the shares. The analyst expects the company's Q2 results to exceed expectations as multiple data points suggest results are trending better than initially feared. He noted the multiple is now near an all-time high and that investor sentiment remains positive.

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

07/06/20
Fly Intel: Top five analyst upgrades
07/06/20 Citi
Tandem Diabetes upgraded to Buy from Neutral at Citi
07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
TNDM TNDM
/

+

TNDM TNDM
/

+

Hot Stocks
Medtronic receives FDA, CE Mark approval for Linq II ICM » 09:20
07/07/20
07/07
09:20
07/07/20
09:20
MDT

Medtronic

$93.20 /

+0.06 (+0.06%)

Medtronic announced it…

Medtronic announced it has received FDA clearance and CE Mark approval for its Linq II insertable cardiac monitor, or ICM, with remote programming, which enables clinicians to optimize device settings without the need for patients to return to the office or hospital. The company said the Linq II system also delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. Linq II is a small, wireless ICM for patients with abnormal heart rhythms who experience infrequent symptoms including dizziness, palpitations, syncope and chest pain, thereby requiring long-term monitoring or ongoing management. The device will be commercially available in the U.S. and Europe later this summer.

ShowHide Related Items >><<
MDT Medtronic
$93.20 /

+0.06 (+0.06%)

MDT Medtronic
$93.20 /

+0.06 (+0.06%)

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
MDT Medtronic
$93.20 /

+0.06 (+0.06%)

MDT Medtronic
$93.20 /

+0.06 (+0.06%)

MDT Medtronic
$93.20 /

+0.06 (+0.06%)

MDT Medtronic
$93.20 /

+0.06 (+0.06%)

Recommendations
Insulet price target raised to $230 from $220 at Cowen » 09:20
07/07/20
07/07
09:20
07/07/20
09:20
PODD

Insulet

$204.54 /

+3.4 (+1.69%)

Cowen analyst Ryan…

Cowen analyst Ryan Blicker raised the firm's price target on Insulet to $230 from $220 and keeps an Outperform rating on the shares. The analyst expects the company's Q2 results to exceed expectations as multiple data points suggest results are trending better than initially feared. He noted the multiple is now near an all-time high and that investor sentiment remains positive.

ShowHide Related Items >><<
PODD Insulet
$204.54 /

+3.4 (+1.69%)

PODD Insulet
$204.54 /

+3.4 (+1.69%)

06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/10/20 Piper Sandler
Tandem Diabetes the 'standout' in Piper endocrinologist survey
06/05/20 Piper Sandler
Insulet offered positive comment on data, says Piper Sandler
05/08/20 Baird
Insulet price target raised to $242 from $189 at Baird
PODD Insulet
$204.54 /

+3.4 (+1.69%)

  • 13
    May
PODD Insulet
$204.54 /

+3.4 (+1.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.